Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm

International Journal of Cardiology

Volumn 81, Issue 2-3, 2001, Pages 151-156

  Masumoto, Akihiro ^a   Mohri, Masahiro ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium channel blockers; Syndrome X

Indexed keywords

ACETYLCHOLINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMIDAPRIL; LISINOPRIL;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY SPASM; DISEASE COURSE; DRUG EFFICACY; EPICARDIUM; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MORTALITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RISK FACTOR; SEX DIFFERENCE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY VASOSPASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; PERICARDIUM; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX FACTORS;

EID: 0035660951     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(01)00540-X     Document Type: Article

References (33)

1. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina
2. Coronary artery spasm: Demonstration, definition, diagnosis, and consequences
3. Calcium channel antagonists in the management of anginal syndromes: Changing concepts in relation to the role of coronary vasospasm
4. Angina pectoris caused by coronary microvascular spasm
5. Ergonovine-induced myocardial ischemia without epicardial coronary vasospasm. Evidence for ischemia produced by small-vessel vasoconstriction
6. Acetylcholine-induced myocardial ischemia without epicardial coronary artery spasm: Possible vasospasm of small coronary arteries. A case report
7. A case of rest angina due to microvascular spasm
8. Cigarette smoking is a major risk factor for coronary spasm
9. Correlation of basal coronary artery tone with constrictive response to ergonovine in patients with variant angina
10. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo
11. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans
12. Angina pectoris and normal coronary arteriograms: Clinical presentation and hemodynamic characteristics
13. Chest pain and normal coronary arteriograms: Role of 'microvascular spasm'
14. Cardiac syndrome X: Clinical characteristics and left ventricular function. A long-term follow-up study
15. Chest pain in women: Clinical, investigative, and prognostic features
16. Is coronary flow reserve in response to papaverine really normal in syndrome X?
17. Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography
18. 17-Beta-estradiol therapy lessens angina in postmenopausal women with syndrome X
19. Long-term follow-up of patients initially diagnosed with syndrome X
20. Ischemic-like ST-segment changes during Holter monitoring in patients with angina pectoris and normal coronary arteries but negative exercise testing
21. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients
22. Significance of coronary artery tone in patients with vasospastic angina
23. Chest pain with angiographically insignificant coronary arterial obstruction. Clinical presentation and long-term follow-up
24. Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries
25. Long-term follow-up in patients with positive exercise test and angiographically normal coronary arteries (syndrome X)
26. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve
27. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X
28. Therapeutic benefits of cilazapril in patients with syndrome X
29. Improvement of coronary flow reserve after long-term therapy with enalapril
30. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina
31. Enalapril-induced regression of hypertensive left ventricular hypertrophy, regional ischemia, and microvascular angina
32. Altered serotonin receptor subtypes mediate coronary microvascular hyperreactivity in pigs with chronic inhibition of nitric oxide synthesis
33. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis